跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
"TBSF" Human Immunoglobulin for Intravenous Use - TGA Drug Approval Details
Approvals
/
TGA
/
"TBSF" Human Immunoglobulin for Intravenous Use
Approved
STANDARD
"TBSF" Human Immunoglobulin for Intravenous Use
CSL Behring (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
4b1e7c2d448b7040
Company
CSL Behring (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
4b1e7c2d448b7040
Product Name
"TBSF" Human Immunoglobulin for Intravenous Use
Artg Id
125811
Artg Name
"TBSF" Human Immunoglobulin for Intravenous Use
Sponsor
CSL Behring (Australia) Pty Ltd
Company Detail Path
/organization/csl-behring-australia-pty-ltd
Artg Date
2006-03-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
4b1e7c2d448b7040
Type
Standard
Back to TGA Approvals
